The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
18 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $8,758,847 in first-year total cost, median $544,305.
Most frequent study sections
- Special Emphasis Panel[ZCA1 TCRB-9 (M1)]7
- Special Emphasis Panel[ZCA1 TCRB-D (M2)]5
- Special Emphasis Panel[ZCA1 TCRB-6 (O1)]3
- Special Emphasis Panel[ZCA1 TCRB-D (M1)]2
- Special Emphasis Panel[ZCA1 TCRB-9 (O1)]1
Most frequent institutions
- CASE WESTERN RESERVE UNIVERSITY2
- UNIVERSITY OF CALIFORNIA LOS ANGELES2
- EMORY UNIVERSITY1
- IOWA STATE UNIVERSITY1
- MASSACHUSETTS GENERAL HOSPITAL1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2017 | Overcoming the immune-suppressive tumor microenvironment through in situ vaccination nanotechnology1U01CA218292-01 | FIERING, STEVENSTEINMETZ, NICOLE FRANZISKA | CASE WESTERN RESERVE UNIVERSITY, OH | $616,764 | ZCA1 |
| 2017 | Imaging of nanotherapeutic drug action1U01CA206997-01A1 | WEISSLEDER, MD, PHD, RALPH | MASSACHUSETTS GENERAL HOSPITAL, MA | $585,707 | ZCA1 |
| 2017 | Nanovaccine platforms to combat pancreatic cancer1U01CA213862-01A1 | JAIN, MANEESHNARASIMHAN, BALAJISALEM, ALIASGER K | IOWA STATE UNIVERSITY, IA | $566,261 | ZCA1 |
| 2017 | STING-Activating Polymeric Nanovaccines for T Cell Therapy of Melanoma1U01CA218422-01 | GAO, JINMING | UT SOUTHWESTERN MEDICAL CENTER, TX | $535,530 | ZCA1 |
| 2017 | Targeted therapeutics for ovarian cancer and its microenvironment - treatment and theoretical modeling1U01CA213759-01 | LOPEZ-BERESTEIN, GABRIEL | UNIVERSITY OF TX MD ANDERSON CAN CTR, TX | $515,198 | ZCA1 |
| 2017 | Nanoparticle Transport Through Tissues1R56CA207839-01A1 | RUOSLAHTI, ERKKI | SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE, CA | $300,000 | ZCA1 |
| 2017 | Nanosensor-Based Phenotypic Screening for Precision Therapy of Cancer Stem Cells1R56CA207932-01A1 | MERCURIO, ARTHUR MROTELLO, VINCENT M. | UNIVERSITY OF MASSACHUSETTS AMHERST, MA | $300,000 | ZCA1 |
| 2017 | Biomimetic nanovesicles to overcome multiple physiological barriers for primary and metastatic triple negative breast cancer therapy1R56CA213859-01A1 | CHANG, JENNY C-N | METHODIST HOSPITAL RESEARCH INSTITUTE, TX | $299,992 | ZCA1 |
| 2017 | Integrated Nano-Therapeutics to Overcome Tumor Plasticity and Resistance1R56CA198492-01A1 | AMIJI, MANSOOR M. | NORTHEASTERN UNIVERSITY, MA | $299,852 | ZCA1 |
| 2016 | Optimizing RNA nanoparticles size and shape for enhancing cancer targeting and treatment1U01CA207946-01 | CARSON, WILLIAM E.GUO, PEIXUANPACK, DANIEL WYU, JIANHUA | OHIO STATE UNIVERSITY, OH | $553,079 | ZCA1 |
| 2016 | Tunable Polymer-Graphene Oxide Composite for Single Cell Analysis of Breast Cancer CTCs & CSCs1R56CA203290-01 | KIM, JINSANGNAGRATH, SUNITHAWICHA, MAX S. | UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI | $299,999 | ZCA1 |
| 2015 | The rodent eye as a non-invasive window for understanding cancer nanotherapeutics1U01CA198880-01 | LAM, KIT S | UNIVERSITY OF CALIFORNIA AT DAVIS, CA | $584,839 | ZCA1 |
| 2015 | Treatment of glioblastoma using chain-like nanoparticles1U01CA198892-01 | KARATHANASIS, EFSTATHIOS | CASE WESTERN RESERVE UNIVERSITY, OH | $576,094 | ZCA1 |
| 2015 | Nanoscale Metal-organic Frameworks for Light Triggered and X-ray Induced Photodynamic Therapy of Head and Neck Cancers1U01CA198989-01 | LIN, WENBINWEICHSELBAUM, RALPH R | UNIVERSITY OF CHICAGO, IL | $575,774 | ZCA1 |
| 2015 | Targeted Core Shell Nanogels for Triple Negative Breast Cancer1U01CA198910-01 | BRONICH, TATIANA KKABANOV, ALEXANDER VLIU, RIHE | UNIV OF NORTH CAROLINA CHAPEL HILL, NC | $575,542 | ZCA1 |
| 2015 | Stroma Breaking Theranostic Nanoparticle for Targeted Pancreatic Cancer Therapy1U01CA198913-01 | MAO, HUIYANG, LILY | EMORY UNIVERSITY, GA | $574,292 | ZCA1 |
| 2015 | UCLA Multifunctional Mesoporous Silica Nanoparticle Platform for Treatment of Pancreas Cancer1U01CA198846-01 | DONAHUE, TIMOTHY RMENG, HUANNEL, ANDRE ELIASZINK, JEFFREY I | UNIVERSITY OF CALIFORNIA LOS ANGELES, CA | $513,147 | ZCA1 |
| 2015 | Thermoresponsive NanoVelcro CTC Purification System for Prostate Cancer Profiling1U01CA198900-01 | POSADAS, EDWIN MELENCIOTSENG, HSIAN-RONG | UNIVERSITY OF CALIFORNIA LOS ANGELES, CA | $486,777 | ZCA1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.